BETHESDA, MD (UroToday.com) - Dr. Ellen Zwarthoff presented data on the FGFR3 assay to stratify patients at risk for recurrence of bladder cancer.
Your session will expire in 8 hours requiring you to log in each day to view content.
Browse Categories
SUO 2008 - Novel Molecular Characteristics: Diagnostic and Therapeutic Implications - Session Highlights
Your session will expire in 8 hours requiring you to log in each day to view content.